Skip to main content

Table 2 Association between FOXO3a expression and clinicopathological features in PDAC patients

From: RETRACTED ARTICLE: Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2

Clinicopathological feature

Total

Expression of FOXO3a

P value

High

Low

130

(n = 63, 48.5%)

(n = 67, 51.5%)

Age(y)

 <60

80

36

44

0.413

 ≥60

50

27

23

Gender

 Male

75

39

36

0.444

 Female

55

24

31

Tumor location

 Head

108

50

58

0.390

 Body/tail

22

13

9

TNM stage (AJCC)

 I

39

35

4

<0.001

 II

78

27

51

 III

7

1

6

 IV

6

0

6

Tumor size (cm)

 ≤2 cm

9

5

4

0.739

 >2 cm

121

58

63

Depth of invasion

 T1, T2

57

40

17

<0.001

 T3, T4

73

23

50

Lymph node metastasis

 N0 (Negative)

79

56

23

<0.001

 N1 (Positive)

51

7

44

Distant metastasis

 M0

124

63

61

0.044

 M1

6

0

6

Vascular invasion

 No

102

51

51

0.648

 Yes

28

12

16

Perineural invasion

 No

117

59

58

0.292

 Yes

13

4

9

Histologic grade

 Well differentiation

18

14

4

<0.001

 Moderate differentiation

67

42

25

 Poor differentiation

45

7

38